RNAi Roundtable: ALN-AAT for the treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

RNAi Roundtable: ALN-AAT for the treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

On August 14, 2015, we hosted an online RNAi Roundtable to review the progress with ALN-AAT in development for the treatment of alpha-1 antitrypsin deficiency-associated liver disease.

View the presentation
Read the transcript



SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.